Oragenics Inc. short interest in 2020
In 2020, Oragenics Inc.'s disclosed short interest ran from 2.71% of shares outstanding on 15 Jan 2020 to 3.42% on 31 Dec 2020, a change of +0.71 percentage points. The year's high was 4.00% on 13 Mar 2020 and its low 1.73% on 30 Jun 2020, averaging 2.86% across 22 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.12 days on 31 Jan 2020. Full history: Oragenics Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 2.71% (15 Jan 2020)
- End of year
- 3.42% (31 Dec 2020)
- Change
- +0.71 pp
- High
- 4.00% (13 Mar 2020)
- Low
- 1.73% (30 Jun 2020)
- Average
- 2.86%
- Highest days to cover
- 3.12 (31 Jan 2020)
- SEC filings marked
- 4
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 2.71% | 2.64 | |
| 31 Jan 2020 | 3.05% | 3.12 | |
| 14 Feb 2020 | 3.50% | 1.00 | |
| 28 Feb 2020 | 3.69% | 1.00 | |
| 13 Mar 2020 | 4.00% | 1.07 | 10-K filed |
| 31 Mar 2020 | 3.47% | 2.37 | |
| 15 Apr 2020 | 3.80% | 1.66 | |
| 30 Apr 2020 | 2.41% | 1.00 | |
| 15 May 2020 | 2.83% | 1.00 | 10-Q filed |
| 29 May 2020 | 2.11% | 1.00 | |
| 15 Jun 2020 | 1.86% | 1.00 | |
| 30 Jun 2020 | 1.73% | 1.00 | |
| 14 Aug 2020 | 2.61% | 1.00 | 10-Q filed |
| 31 Aug 2020 | 3.84% | 1.00 | |
| 15 Sep 2020 | 3.79% | 1.76 | |
| 30 Sep 2020 | 2.55% | 1.00 | |
| 15 Oct 2020 | 2.18% | 1.00 | |
| 30 Oct 2020 | 1.75% | 1.01 | |
| 13 Nov 2020 | 2.91% | 1.67 | 10-Q filed |
| 30 Nov 2020 | 2.41% | 1.00 | |
| 15 Dec 2020 | 2.22% | 1.00 | |
| 31 Dec 2020 | 3.42% | 1.00 |
See also: Oragenics Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.